Verified peer comparison
Revvity vs Neurocrine Biosciences Financial Comparison
Direct answer
Revvity and Neurocrine Biosciences are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Revvity email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revvity Revenue
- 2,856,051,000 USD
- Neurocrine Biosciences Revenue
- 2,860,500,000 USD
- Revvity Operating income
- 356,635,000 USD
- Neurocrine Biosciences Operating income
- 619,100,000 USD